Michael March Schmidt,Thomas M. Barnes,David V. Erbe,Eric Steven Furfine,Alison Tisdale
申请号:
US14508068
公开号:
US09951130B2
申请日:
2014.10.07
申请国别(地区):
US
年份:
2018
代理人:
摘要:
Interleukin 6 (IL-6) antagonists are provided that are specific for binding to site II of IL-6. Methods of using such inhibitors to treat IL-6 related diseases, e.g., disease of the eye such as diabetic macular edema are disclosed.